SPIA
ONCE

Steward Partners Investment Advisory’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Steward Partners Investment Advisory’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$6K – 2602
2018
Q1 		$6K Hold
100
– – ﹤0.01% 1760
2017
Q4 		$5K Hold
100
– – ﹤0.01% 1542
2017
Q3 		$8K Hold
100
– – ﹤0.01% 1189
2017
Q2 		$5K Sell
100
-100
-50% -$5.59K ﹤0.01% 1247
2017
Q1 		$10K Buy
+200
New +$11.9K ﹤0.01% 959

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Steward Partners Investment Advisory's ONCE Position: Q2 2018 in Review

Steward Partners Investment Advisory sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2018, closing a stake of 100 shares — an estimated $6K sold.

Steward Partners Investment Advisory first reported a position in ONCE in Q1 2017 and held it in 5 quarters. The position peaked at $10K in Q1 2017. 172 funds tracked by Wall St. Rank hold ONCE as of Q2 2018.

  • Steward Partners Investment Advisory reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 100 Spark Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $6K.
  • Steward Partners Investment Advisory first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2017 and held it in 5 quarters.
  • Steward Partners Investment Advisory's Spark Therapeutics, Inc. Common Stock position peaked at $10K in Q1 2017.
  • 172 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2018, filed 20 Jul 2018.